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ABSTRACT
Background
Measurement of cervical length by ultrasound is predictive of preterm birth (PTB). There are three methods of ultrasound cervical assessment: transvaginal (TVU), transabdominal (TAU), and transperineal (TPU, also called translabial). Cervical length measured by TVU is a
relatively new screening test, and has been associated with better prediction of PTB than previously available tests. It is unclear if cervical
length measured by ultrasound is effective for preventing PTB. This is an update of a review last published in 2013.
Objectives
To assess the effectiveness of antenatal management based on transvaginal, transabdominal, and transperineal (also called translabial)
ultrasound screening of cervical length for preventing preterm birth.
Search methods
For this update, we searched the Cochrane Pregnancy and Childbirth’s Trials Register, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform (ICTRP) to 30 August 2018; reviewed the reference lists of all articles, and contacted experts in the field for
additional and ongoing trials.
Selection criteria
We included published and unpublished randomised controlled trials (RCT) including pregnant women between the gestational ages of
14 to 32 weeks, for whom the cervical length was screened for risk of PTB with TVU, TAU, or TPU. This review focused on studies based
on knowledge versus no knowledge of cervical length results, or ultrasound versus no ultrasound for cervical length. We excluded studies
based on interventions (e.g. progesterone, cerclage) for short cervical length.
Data collection and analysis
We followed standard Cochrane methods.
Main results
We included seven RCTs (N = 923): one examined asymptomatic women with twin pregnancies; four included women with singleton pregnancies and symptoms of preterm labour (PTL); one included women with singleton pregnancies and symptoms of preterm premature
rupture of membranes (PPROM); and one included asymptomatic singletons. All trials used TVU for screening.
We assessed the risk of bias of the included studies as mixed, and the quality of the evidence for primary outcomes as very low for all
populations.
Cervical assessment by ultrasound for preventing preterm delivery (Review)
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For asymptomatic women with twin pregnancies, it is uncertain whether knowledge of TVU-measured cervical length compared to no
knowledge reduces PTB at less than 34 weeks (risk ratio (RR) 0.62, 95% confidence intervals (CI) 0.30 to 1.25; 1 study, 125 participants)
because the quality of the evidence is very low. The results were also inconclusive for preterm birth at 36, 32, or 30 weeks; gestational age
at birth, and other maternal and perinatal outcomes.
Four trials examined knowledge of TVU-measured cervical length of singletons with symptoms of PTL versus no knowledge. We are uncertain of the effects because of inconclusive results and very low-quality evidence for: preterm births at less than 37 weeks (average RR 0.59,
95% CI 0.26 to 1.32; 2 studies, 242 participants; I2 = 66%; Tau2 = 0.23). Birth occurred about four days later in the knowledge groups (mean
difference (MD) 0.64 weeks, 95% CI 0.03 to 1.25; 3 trials, 290 women). The results were inconclusive for the other outcomes for which there
were available data: PTB at less than 34 or 28 weeks; birthweight less than 2500 g; perinatal death; maternal hospitalisation; tocolysis;
and steroids for fetal lung maturity.
The trial of singletons with PPROM (N = 92) evaluated safety of using TVU to measure cervical length in this population as its primary
outcome, not its effect on management. The results were inconclusive for incidence of maternal and neonatal infections between the TVU
and no ultrasound groups.
In the trial of asymptomatic singletons (N = 296), in which women either received TVU or not, the results were inconclusive for preterm
birth at less than 37 weeks (RR 1.27, 95% CI 0.61 to 2.61; I2 = 0%), gestational age at birth, and other perinatal and maternal outcomes.
We downgraded evidence for limitations in study design, inconsistency between the trials, and imprecision, due to small sample size and
wide confidence intervals crossing the line of no effect.
No trial compared the effect of knowledge of the CL with no knowledge of CL in other populations, such as asymptomatic women with
singleton pregnancies, or symptomatic women with twin pregnancies.
Authors' conclusions
There are limited data on the effects of knowing the cervical length, measured by ultrasound, for preventing preterm births, which preclude
us from drawing any conclusions for women with asymptomatic twin or singleton pregnancies, singleton pregnancies with PPROM, or
other populations and clinical scenarios.
Limited evidence suggests that knowledge of transvaginal ultrasound-measured cervical length, used to inform the management of
women with singleton pregnancies and symptoms of preterm labour, appears to prolong pregnancy by about four days over women in
the no knowledge groups.
Future studies could look at specific populations separately (e.g. singleton versus twins; symptoms versus no symptoms of PTL), report on
all pertinent maternal and perinatal outcomes, and include cost-effectiveness analyses. Most importantly, future studies should include
a clear protocol for management of women based on TVU-measured cervical length.

PLAIN LANGUAGE SUMMARY
Cervical assessment by ultrasound for preventing preterm delivery
We set out to assess the effectiveness of knowing the cervical length, measured with ultrasound, for preventing preterm birth compared
with not knowing the cervical length.
What is the issue?
The cervix is the lower part of the uterus that connects to the vagina. When women are not pregnant, it is normally at least 3 cm long. During
pregnancy, a short cervical length is associated with a risk of spontaneous preterm birth. The shorter the cervical length, the greater the
risk. Therefore, measuring cervical length by ultrasound can help predict spontaneous preterm birth. The cervical length is measured by an
ultrasound scan through the vagina (transvaginal or TVU), abdomen (transabdominal), or the perineum (transperineal). The most common
causes of spontaneous preterm birth are preterm labour or preterm premature rupture of the membranes. Many of the interventions used
to prevent preterm birth are used once symptoms develop.
Why is this important?
Preterm birth before 37 weeks is the main cause of a newborn baby being sick and disabled, or dying. The cervix is the opening or passage
through which the baby must pass before being born vaginally. Ultrasound can detect early changes of the cervix, such as shortening of
the cervical length, to predict preterm birth. On identifying a short cervical length, interventions can be applied to prevent preterm birth.
These interventions include giving the expectant mother progesterone to relax the uterus, or applying a stitch, known as a cerclage, to
tighten the opening of the cervix.
What evidence did we find?
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This review assessed if knowing the cervical length can prevent preterm birth. We included seven randomised controlled studies, which
involved 923 pregnant women at 14 to 32 weeks' gestation. One study included expectant mothers with twins, without any symptoms of
preterm birth or labour, and looked at the number of babies born prematurely before 36 weeks. Four studies included expectant mothers
of single babies with threatened preterm labour, and one study involving women with premature rupture of the membranes looked at the
safety of transvaginal ultrasound. One trial included expectant mothers with singleton pregnancies who did not have any symptoms of
preterm birth or labour to look at the efficacy of transvaginal ultrasound cervical length screening. All studies used transvaginal ultrasound
to assess cervical length.
For women with twin pregnancies and not showing symptoms of preterm birth, we are unclear of the impact of knowing the cervical length
on whether babies are born before 34 weeks' gestation, or their gestational age at birth (1 study, 125 women), because we assessed the
quality of the evidence to be very low. For women with a single baby and threatened preterm labour, knowledge of their cervical length
may have led to a longer pregnancy by about four days (4 studies, 410 women), but the evidence on the number of babies born before 37
weeks was unclear (2 studies, 242 women). For women whose waters had broken, it is unclear whether healthcare provider knowledge
makes any difference to whether the women gave birth preterm, or on the number of infections, again because we judged the quality of
evidence as very low. For women with singleton pregnancies not showing symptoms of preterm birth, it is unclear whether an ultrasound
to measure cervical length made any difference to whether their babies were born before 37 weeks' gestation (1 study, 296 women; very
low-quality evidence).
What does this mean?
We found a limited number of studies including small numbers of women. The studies varied in their design and had a broad spread of
results. Women were not blinded to whether they had an ultrasound or not. Currently, there is not enough high quality research to show if
knowledge of cervical length in women with twin or singleton pregnancies has any effect. Future studies could include ways of managing
women as a result of the cervical length results, and it would be useful to look at specific populations separately, such as single babies
versus twins and women with and without symptoms of preterm labour. They could also report on all important maternal and perinatal
outcomes, and include cost-effectiveness analyses.
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Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length

Outcomes

Anticipated absolute effects* (95% CI)
Risk with no knowledge of CL

Preterm birth
< 34 weeks

№ of participants
(studies)

Quality of the evidence
(GRADE)

RR 0.62
(0.30 to 1.25)

125
(1 RCT)

⊕⊝⊝⊝
VERY LOW a, b

Risk with knowledge of CL

Study population (asymptomatic women carrying twins)
258 per 1000

Relative effect
(95% CI)

Comments

Trusted evidence.
Informed decisions.
Better health.

Patient or population: women carrying twins, asymptomatic for PTL or PPROM
Setting: USA, setting not specified
Intervention: knowledge of TVU-measured cervical length (CL)
Comparison: no knowledge of CL

Cochrane

Summary of findings for the main comparison. Asymptomatic women with twins (no preterm labour (PTL) or preterm premature rupture of
membranes (PPROM))
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SUMMARY OF FINDINGS

160 per 1000
(77 to 323)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; RR: risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect

bWe downgraded 1 level for serious limitations in study design, due to unclear risk of bias for several domains, and high risk of performance bias

Summary of findings 2. Symptomatic singletons (with preterm labour (PTL))
Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length
Patient or population: singleton pregnancy with symptoms of PTL
Setting: hospital settings in Spain and USA
4
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aWe downgraded 2 levels for very serious imprecision due to wide CI crossing the line of no effect, few events, and small sample size

Anticipated absolute effects* (95% CI)
Risk with no knowledge of CL

Quality of the evidence
(GRADE)

Average RR 0.59
(0.26 to 1.32)

242
(2 RCTs)

⊕⊝⊝⊝
VERY LOWa,b,c

Risk with knowledge of
CL

Study population (symptomatic singletons)
347 per 1000

№ of participants
(studies)

Comments

222 per 1000
(146 to 337)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

Trusted evidence.
Informed decisions.
Better health.

Preterm birth
< 37 weeks

Relative effect
(95% CI)
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Intervention: knowledge of TVU-measured cervical length (CL)
Comparison: no knowledge of CL

CI: confidence interval; RR: risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
aWe downgraded 1 level for serious inconsistency due to high statistical heterogeneity (66%)
bWe downgraded 2 levels for very serious imprecision due to a small sample size and wide confidence intervals crossing the line of no effect
cWe downgraded 1 level for serious limitations in study design due to high risk of bias for several domains
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BACKGROUND
Description of the condition
Preterm birth (PTB) is defined by the World Health Organization
(WHO) as birth between 20 and 36 6/7 weeks. PTB can be spontaneous, and follow preterm labour (PTL (50%)), or preterm premature rupture of membranes (PPROM (30%)). It can also be iatrogenic
(caused by health worker intervention (20%). Its incidence is about
5% to 12% in most countries, accounting for over a million deaths
per year in the world. PTB is the main cause of neonatal morbidity and mortality in most countries. In the USA, 75% of perinatal
mortality occurs in preterm babies; 60% of total perinatal mortality
occurs in infants born before 32 weeks. Mortality and morbidities
are inversely associated with gestational age at birth. Morbidities
include respiratory distress syndrome, bronchopulmonary dysplasia, intraventricular haemorrhage, necrotizing enterocolitis, sepsis,
retinopathy, etc. The whole family suffers greatly in several aspects
when a baby has been born prematurely, including medically, socially, psychologically, and financially.

Cochrane Database of Systematic Reviews

2017a; Dodd 2017b), cerclage (Alfirevic 2017; Rafael 2014); or pessary (Abdel-Aleem 2013). Knowledge of cervical length assessment
by ultrasound per se can also be considered an intervention, and
is the topic of this review. In addition, cervical length assessment
could also reduce the need for other interventions (e.g. activity restriction, tocolytics, steroids, etc.).

Why it is important to do this review
PTB is the main cause of neonatal morbidity and mortality in
most countries. It account for a neonatal death every 30 seconds
globally, and millions of babies are affected by its consequences
every year. Mortality and morbidities are inversely associated with
gestational age at birth. Morbidities include respiratory distress
syndrome, bronchopulmonary dysplasia, intraventricular haemorrhage, necrotizing enterocolitis, sepsis, retinopathy, etc. The whole
family suffers greatly in several aspects when a baby has been
born prematurely, including medically, socially, psychologically,
and financially. This is an update of a review last published in 2013
(Berghella 2013).

Description of the intervention

OBJECTIVES

Many of the interventions studied have been aimed at tertiary prevention, i.e. prevention once symptoms (e.g. PTL or PPROM) develop. Interventions based on risk factors, usually based on prior history, have been more recently developed. There are three methods of
ultrasound cervical assessment: transvaginal (TVU), transabdominal (TAU), and transperineal (TPU, also called translabial). Cervical length measured by transvaginal ultrasound (TVU) is a relatively new screening test, and has been associated with better prediction of PTB than previously available tests (Berghella 2003, Berghella 2017,Navathe 2019). Interventions based on this screening test
have now been tested in randomised trials.

To assess the effectiveness of antenatal management based
on transvaginal, transabdominal, and transperineal (also called
translabial) ultrasound screening of cervical length for preventing
preterm birth.

How the intervention might work
Cervical assessment by ultrasound has been correlated with the
prediction of spontaneous PTB (Berghella 2003). The most objective and effective ultrasound method is TVU (Hernandez-Andrade
2012; Khalifeh 2016). The most predictive and reproducible variable that can be measured on TVU is cervical length. The gestational age at which TVU cervical length is most predictive of PTB
is 14 to 34 weeks, but shortening at earlier and later gestational
ages is also associated with PTB. The shorter the cervical length,
the higher the risk of PTB becomes (Grimes-Dennis 2007). The earlier in gestation the shortening is detected, the higher the risk of
PTB (Berghella 2007). This prediction has been confirmed in all populations screened with TVU cervical length so far, including singleton and multiple pregnancies, women with or without risk factors for PTB (e.g. prior PTB, mullerian anomalies, cervical surgery,
etc.), asymptomatic women, as well as those with PTL or PPROM
(Grimes-Dennis 2007). In fact, TVU cervical length is one of the best
predictors of PTB in all populations studied so far. The overall sensitivity and specificity vary according to the cervical length cut-off
used (e.g. 25 mm versus 20 mm versus 15 mm); gestational age at
screening; population studied; prevalence of PTB; single versus serial screening; etc. Its positive predictive value also varies depending
on the incidence of PTL in the population studied. The intervention
of cervical length assessment by ultrasound has been studied in
combination with other interventions (e.g. cerclage, progesterone,
pessary, etc.) for prevention of PTB, and the reader is encouraged
to read these specific Cochrane Reviews (e.g. progesterone (Dodd

METHODS
Criteria for considering studies for this review
Types of studies
Published and unpublished randomised controlled trials. We had
planned to include cluster-randomised and quasi-randomised trials, if available. Abstracts were eligible for inclusion if sufficient information was provided to judge the quality and potential for bias
of these trials.
Types of participants
Pregnant women between the gestational ages of 14 to 34
weeks, screened with transvaginal (TVU), transabdominal (TAU),
or transperineal (TPU) cervical length for risk of preterm birth
(PTB). Given the different characteristics of singleton versus
twin pregnancies; women with asymptomatic versus symptomatic
preterm labour (PTL) or preterm premature rupture of membranes
(PPROM); and PTL versus PPROM; we divided comparisons into:
•
•
•
•
•
•

asymptomatic singletons
asymptomatic with twins
singletons with PTL
singleton with PPROM
twins with PTL
twins with PPROM

We had planned to divide the analysis by the type of cervical length
ultrasound screening, i.e. TVU versus TAU versus TPU. We carried
out analysis of other participants by type of population, as described under 'subgroup analyses'.

Cervical assessment by ultrasound for preventing preterm delivery (Review)
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Trials that did not measure the outcome of interest, as well as trials using manual digital cervical examination as control group were
excluded.
Types of interventions
A screening test such as clinical length can only be considered effective if the interventions based on screening results reduce the outcome of preterm birth. For this review, we included the following
screening cervical length modalities on which interventions were
based.
• Knowledge versus no knowledge of cervical length results (i.e.
cervical length is assessed for all women, but women are randomised so that in about 50% of them, the result is available to
the managing obstetrician, while in about 50%, the managing
obstetrician is blind to the result).
• Cervical length screening versus no cervical length screening
(TVU/TAU/TPU cervical length screening is only performed on
half of the women).
Types of outcome measures
Primary outcomes
1. Preterm birth (less than 37 weeks for singleton pregnancies; less
than 34 weeks for twin pregnancies)
Secondary outcomes
1.
2.
3.
4.
5.
6.
7.
8.
9.

Preterm birth (less than 36 weeks)
Preterm birth (less than 34 weeks)
Preterm birth (less than 32 weeks)
Preterm birth (less than 30 weeks)
Preterm birth (less than 28 weeks)
Gestational age at delivery
Birthweight less than 2500 g
Birthweight (g)
Composite perinatal outcome (perinatal death, respiratory distress syndrome, intraventricular haemorrhage, necrotizing enterocolitis, and sepsis)
10.Perinatal death (fetal death and neonatal death)
11.Fetal death
12.Neonatal death
13.Neonatal infection
14.Respiratory distress syndrome
15.Intraventricular haemorrhage
16.Necrotizing enterocolitis
17.Sepsis
18.Neonatal intensive care unit (NICU) admission
19.NICU days
20.Maternal hospitalisation
21.Maternal well-being (e.g. stress level, etc.)
22.Economic analysis (cost effectiveness, cost utility)
23.Tocolysis
24.Cervical cerclage
25.Steroids for fetal maturity
26.Chorioamnionitis
27.Endometritis
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Search methods for identification of studies
The following methods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Electronic searches
For this update, we searched Cochrane Pregnancy and Childbirth’s
Trials Register by contacting their Information Specialist (30 August
2018).
The Register is a database containing over 24,000 reports of controlled trials in the field of pregnancy and childbirth. It represents
over 30 years of searching. For full current search methods used to
populate Pregnancy and Childbirth’s Trials Register, including the
detailed search strategies for CENTRAL, MEDLINE, Embase, and CINAHL; the list of handsearched journals and conference proceedings; and the list of journals reviewed via the current awareness service, please follow this link.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist, and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of Controlled
Trials (CENTRAL);
2. weekly searches of MEDLINE Ovid;
3. weekly searches of Embase Ovid;
4. monthly searches of CINAHL EBSCO;
5. handsearches of 30 journals and the proceedings of major conferences;
6. weekly current awareness alerts for a further 44 journals, plus
monthly BioMed Central email alerts.
Search results are screened by two people, and the full text of all
relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then
added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords.
This results in a more specific search set that has been fully accounted for in the relevant review sections (Included studies; Excluded studies; Ongoing studies).
In addition, we searched ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) for unpublished,
planned, and ongoing trial reports (30 August 2018), using the
search methods detailed in Appendix 1.
Searching other resources
We reviewed the reference list of all retrieved articles. If necessary,
we contacted researchers to provide further information. We contacted experts in the field for additional and ongoing trials.
We did not apply any language or date restrictions.

Data collection and analysis
For methods used in the previous version of this review, see
Berghella 2013.
For this update, the following methods were used to assess the reports that were identified as a result of the updated search.
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Selection of studies
Two review authors independently assessed for inclusion all the
potential studies identified as a result of the search strategy. We resolved any disagreement through discussion. Two ongoing studies
are being conducted by one of the authors of this review, so these
were assessed by the Cochrane Pregancy and Childbirth Group staff
(NCT02923973; NCT02928302).
Data extraction and management
We designed a form to extract data. Data were entered into Review Manager 5 software, and checked for accuracy (Review Manager 2014). One of the authors of this Cochrane Review (Vincenzo
Berghella) is a co-author of one of the included trials (Ness 2007),
and the other author (Gabriele Saccone) is lead author on two
ongoing trials (NCT02923973; NCT02928302). Gabriele Saccone assessed the eligibility and risk of bias for Ness 2007; the Cochrane
Pregancy and Childbirth editorial staff assessed the eligibility of
NCT02923973 and NCT02928302. The two review authors independently assessed the other potential studies, identified as a result
of the search strategy for inclusion. We resolved any disagreement
through discussion.
When information regarding any of the above was unclear, we had
planned to contact authors of the original reports to provide further
details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). Any disagreement
was resolved by discussion.
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(3.1) Blinding of participants and personnel (checking for
possible performance bias)
For each included study, we described the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if they were blinded, or if we judged that the
lack of blinding was unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high, or unclear risk of bias for participants;
• low, high, or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
For each included study, we described the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high, or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)

For each included study, we described the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.

For each included study, and for each outcome or class of outcomes, we described the completeness of data including attrition
and exclusions from the analysis. We stated whether attrition and
exclusions were reported, and the numbers included in the analysis
at each stage (compared with the total randomised participants),
reasons for attrition or exclusion where reported, and whether
missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re-include missing data in
the analyses which we undertook.

We assessed the method as:

We assessed methods as:

• low risk of bias (any truly random process, e.g. random number
table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even date
of birth; hospital or clinic record number);
• unclear risk of bias.

• low risk of bias (e.g. no missing outcome data; missing outcome
data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation);
• unclear risk of bias.

(1) Random sequence generation (checking for possible
selection bias)

(2) Allocation concealment (checking for possible selection bias)
For each included study, we described the method used to conceal allocation to interventions prior to assignment, and assessed
whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.

(5) Selective reporting (checking for reporting bias)
For each included study, we described how we investigated the
possibility of selective outcome reporting bias and what we found.

We assessed the methods as:

We assessed the methods as:

• low risk of bias (e.g. telephone or central randomisation; consecutively numbered, sealed, opaque envelopes);
• high risk of bias (open random allocation; unsealed or nonopaque envelopes, alternation; date of birth);
• unclear risk of bias.

• low risk of bias (where it was clear that all of the study’s pre-specified outcomes and all expected outcomes of interest to the review have been reported);
• high risk of bias (where not all the study’s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest were report-
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ed incompletely and so could not be used; study failed to include
results of a key outcome that would have been expected to have
been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not covered by
(1) to (5) above)
For each included study, we described any important concerns we
had about other possible sources of bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). With
reference to (1) to (6) above, we had planned to assess the likely
magnitude and direction of the bias and whether we considered it
was likely to impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity
analyses - see Sensitivity analysis.
Assessment of the quality of the evidence using the GRADE
approach
For this update, we used the GRADE approach, as outlined in the
GRADE Handbook, in order to assess the quality of the body of evidence relating to the primary outcome (preterm birth less than 37
weeks for singleton pregnancies; less than 34 weeks for twin pregnancies) for the following comparisons (GRADE Handbook).
1. Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (asymptomatic women with
twins)
2. Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (symptomatic singletons with
preterm labour (PTL))
We used GRADEpro GDT to import data from Review Manager 5 to
create ’Summary of findings’ tables (GRADEpro GDT; Review Manager 2014). The GRADE approach uses five considerations (study
limitations, consistency of effect, imprecision, indirectness, and
publication bias) to assess the quality of the body of evidence for
each outcome. The evidence can be downgraded from high quality by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of
evidence, serious inconsistency, imprecision of effect estimates, or
potential publication bias.
Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
Continuous data
We used the mean difference if outcomes were measured in the
same way between trials. In future updates, as appropriate, we
plan to use the standardised mean difference to combine trials that
measure the same outcome, but use different methods.
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Unit of analysis issues
Cluster-randomised trials
We had planned to include cluster-randomised trials in the analyses along with individually-randomised trials, however, all included studies were individually-randomised trials.
Dealing with missing data
For included studies, we noted levels of attrition. We had planned
to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis, however, because most trials had a unique comparison, there were too few data available to carry out a meaningful sensitivity analysis.
For all outcomes, we carried out analyses, as far as possible, on
an intention-to-treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention.
The denominator for each outcome in each trial was the number
randomised minus any participants whose outcomes were known
to be missing.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the Tau2, I2, and Chi2 statistics. We regarded heterogeneity as substantial if an I2 was greater than 30%, and either the Tau2 was
greater than zero, or there was a low P value (less than 0.10) in the
Chi2 test for heterogeneity.
Assessment of reporting biases
In future updates, if there are 10 or more studies in the meta-analysis, we will investigate reporting biases (such as publication bias)
using funnel plots. We will assess funnel plot asymmetry visually.
If asymmetry is suggested by a visual assessment, we will perform
exploratory analyses to investigate it.
Data synthesis
We carried out statistical analysis using Review Manager 5 software
(Review Manager 2014). We used a fixed-effect meta-analysis for
combining data where it was reasonable to assume that studies
were estimating the same underlying treatment effect, i.e. where
trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar.
If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial
statistical heterogeneity was detected, we used a random-effects
meta-analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. We
treated the random-effects summary as the average range of possible treatment effects, with 95% confidence intervals, and the estimates of Tau2 and I2, and discussed the clinical implications of
treatment effects differing between trials. If the average treatment
effect was not clinically meaningful, we did not combine trials.
Subgroup analysis and investigation of heterogeneity
We planned the following subgroup analyses, classifying whole trials by interaction tests as described by Deeks 2001.
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1. Women with singleton pregnancies without prior spontaneous
PTB
2. Women with singleton pregnancies with prior spontaneous PTB
We had planned to restrict subgroup analyses to the primary outcome.
We had planned to assess subgroup differences by interaction tests
available within Review Manager 5 (Review Manager 2014).
None of the included studies reported results separately for singleton pregnancies based on prior or no prior spontaneous PTB, so
we could not perform the planned subgroup analysis. In future updates, assuming we have sufficient data, we will report the results
of subgroup analyses, quoting the Chi2 statistic and P value, and
the interaction test I2 value.

Cochrane Database of Systematic Reviews

Sensitivity analysis
We had planned to carry out sensitivity analyses to explore the effect of the trials' methodological quality, assessed by concealment
of allocation, high attrition rates, or both, when studies with high
risk of bias were excluded from the analyses, to assess whether this
made any difference to the overall result.
We did not carry out a sensitivity analysis because most metaanalyses only included data from one or two studies.

RESULTS
Description of studies
Results of the search
See: Figure 1.
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Figure 1. Study flow diagram

For this 2018 update, we identified 17 trial reports to assess. We included two new trials in three reports (Mishra 2018; Vafaei 2017);
and five reports related to three already included studies (Gor-

don 2016; Ness 2007; Palacio 2018). We excluded four new trials
in five reports (Gauthier 2014; Hosseini 2012; Romero 2014; Sch-
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nettler 2013); and added three ongoing studies in four reports
(NCT01431885; NCT02923973; NCT02928302).
In this update, we included a total of seven trials (N = 923). We
identified no quasi-randomised trials. All seven included studies
used transvaginal (TVU) cervical length screening, versus either
no TVU cervical length screening, or no knowledge of the results
of TVU cervical length screening. We did not identify any studies
that used transabdominal or transperineal ultrasound for cervical
length screening.
Included studies
The seven included studies included: one trial on women with
twins, who were asymptomatic for preterm labour (PTL (Gordon
2016)); four trials on women with singleton pregnancies, who had
symptoms of PTL (Alfirevic 2007; Ness 2007; Palacio 2018; Vafaei
2017); one trial on women with singleton pregnancies, who had
preterm premature rupture of membranes (PPROM (Carlan 1997));
no trials included women with twin pregnancies, who were symptomatic for either PTL or had PPROM.
Five studies did not measure cervical length with TVU in the control groups (Alfirevic 2007; Carlan 1997; Gordon 2016; Mishra 2018;
Vafaei 2017); and two studies used TVU to measure cervical length
on all women, but only disclosed knowledge of cervical length to
women and physicians in the intervention group (Ness 2007; Palacio 2018).
We requested patient-level data from most of the trial authors, and
obtained them from one (Ness 2007).
In the one trial of women with twin pregnancies, who were asymptomatic for PTL, the analysis included 63 women who had TVUmeasured cervical length and 62 who did not (Gordon 2016).
In the three trials of women with singleton pregnancies, who had
symptoms of PTL, 410 women were randomised; 212 to knowledge,
and 198 to no knowledge of TVU-measured cervical length (Alfirevic
2007; Ness 2007; Palacio 2018). Ness 2007 used knowledge of the
cervical length in the management protocol; for women with cervical length 20 mm to 29 mm, they also used fetal fibronectin levels
(FFN).
In the one trial of women with singleton pregnancies and PPROM,
the analysis included 47 women who had TVU measurement of cervical length, and 45 who did not (Carlan 1997).
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Funding
Only one trial reported on funding, and reported that the study
was funded by The Fetal Medicine Foundation (Registered Charity
1037116 (Alfirevic 2007)), and one trial reported support from the
Vice-Chancellor of Research, Shiraz University of Medical Sciences,
Shiraz, Iran (Vafaei 2017). None of the other trials reported on funding.
Declarations of interest
Two studies reported that the authors had no conflicts of interest
(Mishra 2018; Vafaei 2017). In the remaining studies, they did not
report on declarations of interest.
Dates of study
Dates were not reported in two studies (Gordon 2016; Vafaei 2017).
The dates were reported as follows in the remaining studies: 2003
to 2005 (Alfirevic 2007); May 1993 to June 1996 (Carlan 1997); July
2014 to December 2015 (Mishra 2018); November 2004 to April 2006
(Ness 2007); and January 2002 to April 2005 (Palacio 2018).
Excluded studies
We excluded a total of 12 trials (14 reports); three because they
compared history-indicated to ultrasound-indicated cerclage (Beigi 2005; Kassanos 2001; Simcox 2009); one because the TVU-measured cervical length information was blinded and not used for
management (Matijevic 2006); one because TVU information was
not used for clinical care and no data on outcomes were provided
(Owen 1999); two trials were excluded because control group was
not ’no ultrasound’ or ’no knowledge’, but was manual digital cervical examination, interestingly, these studies utilized transabdominal ultrasound (Lorenz 1990; Van Dijken 1991); one because it used
Cervilenz, which measures the vaginal part of the cervix rather than
cervical length (Burwick 2011); one because TVU was compared to
TPU, therefore with no 'no knowledge' group (Gauthier 2014); one
because it was unclear if women were randomised to knowledge
versus no knowledge of cervical length groups, and no outcome
of interest was reported (Hosseini 2012); and one because no data
on any outcomes of interest were measured and available, as this
was a trial assessing only visit length and patient attitudes (Romero
2014).

Risk of bias in included studies
See Figure 2 and Figure 3 for summaries of 'Risk of bias' assessments.
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Figure 2. 'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies

Cervical assessment by ultrasound for preventing preterm delivery (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

13

Cochrane

Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 3. 'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study

Allocation
We assessed risk of selection bias as low in four trials (Alfirevic 2007;
Carlan 1997; Ness 2007; Palacio 2018). Alfirevic 2007, Ness 2007,
and Palacio 2018 used computer-generated random numbers for
sequence generation, and Carlan 1997 reported that they used randomly-generated assignment in sealed envelopes.

Alfirevic 2007, Carlan 1997, and Gordon 2016 reported using consecutively numbered, sealed envelopes and Palacio 2018 used a
central telephone operated platform.
Although Mishra 2018 used computer-generated randomisation,
they reported no details related to allocation concealment, so we
assessed it as unclear. The other two studies reported no information on methods of randomisation or allocation concealment, so
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we assessed them as unclear for selection bias (Gordon 2016;Vafaei
2017).
Blinding
We assessed risk of performance bias as high in all trials, as participants and researchers were aware of the arm to which they were
randomised, but this was inevitable.
In two trials, the primary outcomes were objective measures, so we
assessed detection bias at low risk (Alfirevic 2007; Gordon 2016). It
was unclear in other trials if outcome assessment had been blinded.
Incomplete outcome data
Information regarding an intention-to-treat analysis was available
for three of the seven trials. Two trials included all women randomised in the intention-to-treat analysis (Alfirevic 2007; Ness
2007). In Carlan 1997, one of the 93 (1%) women randomised was
excluded from the analysis because she delivered immediately. In
one study, there were no losses to follow-up (Vafaei 2017). We assessed these four studies at low risk of attrition bias. We assessed
two trials as high risk because women lost to follow-up were excluded from the analysis (Mishra 2018; Palacio 2018). We could not
assess incomplete outcome data in one trial because the trial was
only reported as an abstract, so data were limited (Gordon 2016).
Selective reporting
We assessed risk of selective reporting as unclear in four trials due
to a lack of information (Gordon 2016; Mishra 2018; Palacio 2018;
Vafaei 2017); and at low risk of bias in the remaining trials as they
reported all expected specified outcomes.
Other potential sources of bias
We assessed the risk of other potential sources of bias as unclear in
two trials; one did not include a baseline characteristics table (Carlan 1997), and another did not provide sufficient information to allow us to assess (Gordon 2016). We judged the remaining studies at
low risk of bias from other sources.

Effects of interventions
See: Summary of findings for the main comparison Asymptomatic women with twins (no preterm labour (PTL) or preterm premature rupture of membranes (PPROM)); Summary of findings 2
Symptomatic singletons (with preterm labour (PTL))
We included seven trials in this review (N = 923).
We found the risk of bias of the included studies to be mixed. For selected important comparisons for the primary outcome, we graded
the quality of the evidence as very low, see Summary of findings for
the main comparison and Summary of findings 2.
Knowledge of transvaginal ultrasound (TVU)-measured
cervical length versus no knowledge (asymptomatic women
with twins)
The effect of knowing the TVU-measured cervical length is unclear
due to very low-quality evidence from a single trial (Summary of
findings for the main comparison; Gordon 2016).
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cal length reduces preterm birth at less than 36 weeks' gestation
(risk ratio (RR) 1.27, 95% confidence interval (CI) 0.85 to 1.90; 125
participants; Analysis 1.1); at less than 34 weeks (RR 0.62, 95% CI
0.30 to 1.25; 125 participants; Analysis 1.2; Summary of findings for
the main comparison); at less than 32 weeks (RR 0.56, 95% CI 0.17
to 1.83; 125 participants; Analysis 1.3); or at less than 30 weeks' gestation (RR 0.20, 95% CI 0.02 to 1.64; 125 participants; Analysis 1.4),
because the quality of the evidence is very low.
The results were also inconclusive for gestational age at delivery
(weeks) (mean difference (MD) 0.20, 95% CI -0.74 to 1.14; 125 participants; Analysis 1.5), maternal hospitalisation (RR 1.29, 95% CI
0.75 to 2.23; 125 participants; Analysis 1.6), tocolysis (RR 1.34, 95%
CI 0.74 to 2.42; 125 participants; Analysis 1.7), steroids for fetal lung
maturity (RR 0.79, 95% CI 0.49 to 1.26; 125 participants; Analysis
1.8), or cervical cerclage (RR 4.92, 95% CI 0.24 to 100.49; 125 participants; Analysis 1.9); or perinatal outcomes: birthweight (MD 142.00,
95% CI -9.95 to 293.95; 250 participants; Analysis 1.10), NICU admission (RR 1.14, 95% CI 0.83 to 1.55; 250 participants; Analysis 1.11),
No other outcomes were reported in this trial.
Knowledge of transvaginal ultrasound (TVU)-measured
cervical length versus no knowledge (singletons with
symptoms of preterm labour (PTL))
In women with a singleton pregnancy who have symptoms of PTL,
we are uncertain of the effects of knowledge of TVU-measured cervical length on preterm births (PTB) at less than 37 weeks' gestation (average RR 0.59, 95% CI 0.26 to 1.32; 2 studies, 242 participants; I2 = 66%; Tau2 = 0.23; very low-quality evidence; Analysis 2.1;
Summary of findings 2); and at less than 34 weeks (RR 0.55, 95% CI
0.25 to 1.20; 3 studies, 256 participants; Analysis 2.2. There were no
preterm births at less than 28 weeks' gestation.
Birth occurred at a slightly later gestational age in the cervical
length knowledge groups compared to the no knowledge groups
(weeks) (MD 0.64, 95% CI 0.03 to 1.25; 3 studies, 290 participants;
Analysis 2.4).
These results were determined mostly by the Ness 2007 trial, which
used TVU-measured cervical length as the main screening test for
guiding management, adding FFN levels to help determine management in women with a cervical length of 20 mm to 29 mm. There
were inconclusive results and often substantial heterogeneity for
all other outcomes for which there were available data: birthweight
less than 2500 g (RR 0.71, 95% CI 0.21 to 2.44; 1 study, 70 participants; Analysis 2.5); maternal hospitalisation (RR 2.94, 95% CI 0.85
to 10.16; 1 study, 93 participants; Analysis 2.7), tocolysis (average
RR 0.85, 95% CI 0.11 to 6.58; 2 studies, 102 participants; I2 = 86%;
Tau2 = 1.89; Analysis 2.8); and steroids for fetal lung maturity (average RR 1.72, 95% CI 0.15 to 19.64; 2 studies, 114 participants; I2 =
91%; Tau2 = 2.83; Analysis 2.9); there were no perinatal deaths reported in either group. Appropriateness of treatment with steroids
for fetal lung maturity was higher in the knowledge versus the no
knowledge group in the one trial that evaluated this outcome (Alfirevic 2007).
Other maternal and fetal outcomes were not reported, or insufficient data were available for meaningful analysis.

In women with twin pregnancies, and without symptoms of
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Knowledge of transvaginal ultrasound (TVU)-measured
cervical length versus no knowledge (singletons with preterm
premature rupture of membranes (PPROM))
One trial of women with a singleton pregnancy and PPROM evaluated the safety of using TVU to measure cervical length in this population, and not the effect on management of knowing the cervical
length (Carlan 1997). They did not report the incidence of preterm
births or gestational age at delivery. The results were inconclusive
for birthweight (MD 31.00 g, 95% CI -162.16 to 224.16; 92 participants; Analysis 3.1), incidence of maternal infections (chorioamnionitis: RR 0.72, 95% CI 0.34 to 1.52; 92 participants; Analysis 3.2, or
endometritis: RR 1.39, 95% CI 0.33 to 5.88; 92 participants; Analysis
3.3), and neonatal infections (RR 1.18, 95% CI 0.50 to 2.78; 92 participants; Analysis 3.4).
The trials did not report other outcomes.
Knowledge of transvaginal ultrasound (TVU)-measured
cervical length versus no knowledge (asymptomatic
singletons)
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nancies, because we found only one small trial that examined each
population.
Knowledge of TVU-measured cervical length to inform the management of women with singleton pregnancies and symptoms of
preterm labour (PTL) appeared to result in births that occurred
about four days later than those born to women in the no knowledge groups. Evidence on other outcomes such as the incidence
of preterm birth before 37 weeks, was unclear. We were unable
to determine the effect of knowledge of TVU-measured cervical
length in the management of women with singleton pregnancies
and preterm premature rupture of membranes (PPROM) because
we found just one small trial on this population. We identified no
trials of women with twin pregnancies with symptoms of either PTL
or PPROM.
There is limited and inconclusive evidence on how the knowledge
of cervical length, assessed by ultrasound could avoid unnecessary
interventions (e.g. tocolytics, steroids, etc.) in women with a normal cervical length.

One trial examined the effects of the knowledge of TVU-measured
cervical length for women with a singleton pregnancy, no symptoms of PTL, and no history of spontaneous preterm birth or second trimester loss (Mishra 2018). The results were inconclusive for
maternal outcomes: preterm birth less than 37 weeks (RR 1.27, 95%
CI 0.61 to 2.61; 296 participants; Analysis 4.1); and for neonatal outcomes: birthweight (MD -10.00 g, 95% CI -135.17 to 115.17; 296 participants; Analysis 4.2); respiratory distress syndrome (RR 2.03, 95%
CI 0.38 to 10.90; 296 participants; Analysis 4.3); NICU admission (RR
2.03, 95% CI 0.19 to 22.12; 296 participants; Analysis 4.4); intraventricular haemorrhage (RR 0.51, 95% CI 0.05 to 5.53; 296 participants;
Analysis 4.5); and neonatal death (RR 0.20, 95% CI 0.01 to 4.19; 296
participants; Analysis 4.6).

Overall completeness and applicability of evidence

The trial did not report other outcomes.

By design, our review did not include an assessment of the effectiveness of interventions based on positive TVU-measured cervical
length (short cervical length), or negative TVU-measured cervical
length screening (normal or long cervical length). These are examined in Cochrane Reviews of the specific intervention (e.g. progesterone (Dodd 2017a; Dodd 2017b), cerclage (Alfirevic 2017; Rafael
2014); and pessary (Abdel-Aleem 2013).

Other comparisons
We did not identify any trials that assessed knowledge versus no
knowledge of TVU-measured cervical length in women with twins
who had symptoms of PTL or PPROM.
We did not identify any trials that compared different types of ultrasound.

All included trials used TVU to measure cervical length; no included trials used transabdominal (TAU) or transperitoneal (TPU) ultrasound. There were no trials comparing knowledge versus no knowledge of TVU-measured cervical length in symptomatic women with
twin pregnancies.
Ness 2007 suggested a protocol of no intervention for women with
a TVU-measured cervical length of at least 30 mm; the addition of
FFN levels for the management of women with a cervical length of
20 mm to 29 mm; and the administration of steroids for fetal lung
maturity and tocolysis for women with a cervical length less than
20 mm (Ness 2007).

All the included trials took place in high-income settings and countries, therefore, our findings are limited to this type of setting.

Subgroup analysis and sensitivity analysis
None of the seven included trials reported data separately for singleton pregnancies with and without prior spontaneous preterm
births, so we could not perform that planned subgroup analysis.
We did not carry a sensitivity analysis because most meta-analyses
included data from only one or two studies.

DISCUSSION
Summary of main results
There are limited data on the effects of knowing the cervical length,
measured by ultrasound for preventing preterm births.
We were unable to determine the effects of the knowledge of transvaginal ultrasound (TVU)-measured cervical length in the management of asymptomatic women with either singleton or twin preg-

Quality of the evidence
The seven included randomised studies were all relatively small,
and blinding was not possible; see Figure 2 and Figure 3.
For the comparison, knowledge of TVU-measured cervical length
versus no knowledge (asymptomatic women with twins), we assessed the evidence to be very low quality for preterm birth less
than 34 weeks. We downgraded the quality for limitations in study
design, small sample size, and wide confidence intervals that
crossed the line of no effect; see Summary of findings for the main
comparison.
For the comparison, knowledge of TVU-measured cervical length
versus no knowledge (singletons with symptoms of PTL), we assessed the evidence to be very low quality for preterm birth less
than 37 weeks. We downgraded the quality for limitations in study
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design, high statistical heterogeneity, small sample size, and wide
confidence intervals that crossed the line of no effect; see Summary of findings 2.

Potential biases in the review process
One of the authors of this Cochrane Review (Vincenzo Berghella) is
a co-author of one of the included trials (Ness 2007), and the other author (Gabriele Saccone) is lead author on two ongoing trials
(NCT02923973; NCT02928302). Gabriele Saccone assessed the eligibility and risk of bias for Ness 2007; the Cochrane Pregancy and
Childbirth editorial staff assessed the eligibility of NCT02923973
and NCT02928302. The two review authors independently assessed
the other potential studies, identified as a result of the search strategy for inclusion. We resolved any disagreement through discussion.

Agreements and disagreements with other studies or
reviews
The evidence presented in this current update has added two new
trials (Mishra 2018; Vafaei 2017). Our overall conclusions remain the
same as those in the previous version (Berghella 2013). The results
of this Cochrane review concur with another IPD meta-analysis of
three trials including a total of 287 singleton gestations with threatened preterm labour between 24 + 0 and 35 + 6 weeks, that showed
that there is a significant association between knowledge of transvaginal ultrasound cervical length and later gestational age at delivery (Berghella 2017). However, our review found no good quality evidence that there was an association between knowledge of
transvaginal ultrasound cervical length and a lower incidence of
preterm birth in women with singleton pregnancies and threatened
PTB, whereas Berghella 2017 did report an association. A retrospective cohort study of women with asymptomatic singleton gestations also suggested an association between TVU screening and
a reduction in preterm labour (Navathe 2019). Our review did not
find the same finding in the single study identified of asymptomatic
women with a singleton gestation (Mishra 2018).

AUTHORS' CONCLUSIONS

Cochrane Database of Systematic Reviews

Limited evidence suggests that knowledge of transvaginal ultrasound-measured cervical length, used to inform the management
of women with singleton pregnancies and symptoms of preterm
labour, appears to prolong pregnancy by about four days over
women in the no knowledge groups.

Implications for research
This review found limited evidence that suggested knowledge of
TVU-measured cervical length might increase slightly the age at
birth, but it had an unclear effect on preterm births at less than 37
weeks, and there were no clear differences in other outcomes, possibly due to the small number of women with symptoms of PTL. The
review authors encourage further research. Future studies could
look at specific populations separately (e.g. singleton versus twins;
symptoms of PTL or no symptoms), report on all pertinent maternal and perinatal outcomes, and include cost-effectiveness analyses. Most importantly, future studies should include a clear protocol for the management of women's pregnancies, based on TVUmeasured cervical length results, so that it can be easily evaluated
and replicated.
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Implications for practice
There are limited data on the effects of knowing the cervical length,
measured by ultrasound, for preventing preterm births, which preclude us from drawing any conclusions.
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CHARACTERISTICS OF STUDIES
Characteristics of included studies [ordered by study ID]
Alfirevic 2007
Methods

RCT

Participants

Singleton pregnancies; uterine contractions at < 34 weeks; and clinical decision to use steroids and tocolytics. N = 41

Interventions

TVU CL knowledge or not (the control group did not receive TVU CL)
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(Continued)

Time TVU CL results available: not specified
Protocol for TVU knowledge group: yes
Outcomes

Primary: incidence of women still pregnant at 7 days

Notes

Intention-to-treat; only singletons; protocol for management of TVU CL group
Short TVU CL (< 15 mm): 7/21 (33%) in knowledge group; not done in other group
Funding: the study was funded by The Fetal Medicine Foundation (Registered Charity 1037116)
Dates of trial: from 2003 to 2005
Setting: 5 hospitals in the United Kingdom, 1 in Spain
Conflicts of interest: not reported

Risk of bias
Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer-generated randomisation

Allocation concealment
(selection bias)

Low risk

Consecutively numbered sealed envelopes

Blinding of participants
and personnel (performance bias)
All outcomes

High risk

Women and physicians knew which group was randomised to 'knowledge' or
'no knowledge'.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Some blinding attempted – "Women allocated to the experimental group had
a transvaginal scan to measure the CL, which was performed by a member of
the research team who was not involved in the care of the patient" – but the
control group did not have a transvaginal scan.
Primary outcome – is an objective outcome (delivery within 7 days)

Incomplete outcome data
(attrition bias)
All outcomes

Low risk

No incomplete outcomes. Intention-to-treat analysis

Selective reporting (reporting bias)

Low risk

Primary outcome was delivery within 7 days. All other outcomes reported

Other bias

Low risk

Baseline characteristics similar

Carlan 1997
Methods

RCT

Participants

Singleton pregnancies; PPROM; 24 to 34 weeks. N = 92

Interventions

TVU CL or not (the control group did not receive TVU CL)
Time TVU CL results available: not specified
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Protocol for TVU knowledge group: no
Outcomes

Primary: maternal infection

Notes

Intention-to-treat; only singletons; PPROM; no protocol (really a safety study for TVU CL in women with
PPROM)
Short TVU CL (< 25 mm): 14/45 (31%) in knowledge group; not done in other group
Funding: not reported
Dates of trial: from May 1993 to June 1996
Setting: Arnold Palmer Hospital for Children and Women, Floride, United States
Conflicts of interest: not reported

Risk of bias
Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Randomly-generated assignment"

Allocation concealment
(selection bias)

Low risk

"Randomly-generated" assignments in sealed envelopes

Blinding of participants
and personnel (performance bias)
All outcomes

High risk

Study group had weekly US while controls had none

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported

Incomplete outcome data
(attrition bias)
All outcomes

Low risk

1% explained

Selective reporting (reporting bias)

Low risk

Primary outcome was chorioamnionitis. All other outcomes reported

Other bias

Unclear risk

No baseline characteristics table

Gordon 2016
Methods

RCT

Participants

Twin pregnancies; asymptomatic and with PTL symptoms; 15 to 34 weeks. N = 125

Interventions

TVU CL screening at 15 to 28 weeks, and if PTL symptoms develop or not (the control group did not receive TVU CL)
Time TVU CL results available: not specified
Protocol for TVU knowledge group: yes
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Outcomes

Primary: length of gestation

Notes

Only abstract published; unclear if intention-to-treat; only twins; protocol for management of TVU CL
group
Short TVU CL not available
Funding: not reported
Dates of trial: not reported
Setting: not reported, assumed United States
Conflicts of interest: not reported

Risk of bias
Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Randomisation not described

Allocation concealment
(selection bias)

Unclear risk

Not described

Blinding of participants
and personnel (performance bias)
All outcomes

High risk

Different protocols for study and control groups

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Primary outcome objective – length of gestation

Incomplete outcome data
(attrition bias)
All outcomes

Unclear risk

No incomplete outcomes mentioned

Selective reporting (reporting bias)

Unclear risk

Primary outcome was gestational age at delivery

Other bias

Unclear risk

Abstract only, so data reported are limited

Mishra 2018
Methods

RCT

Participants

Asymptomatic singleton pregnancies at 16 to 24 6/7 weeks. N = 296

Interventions

TVU CL performed or not (the control group did not receive TVU CL) at the time of the routine anatomy
screening
Protocol for TVU group: yes

Outcomes

Primary: PTB < 37 weeks

Notes

Funding: not reported
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Dates of trial: July 2014 to December 2015
Setting: Department of Obstetrics & Gynaecology, Postgraduate Institute of Medical Education and Research, Chandigarh, North India
Conflicts of interest: the authors reported no conflicts of interest
Risk of bias
Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer-generated randomisation

Allocation concealment
(selection bias)

Unclear risk

Not reported

Blinding of participants
and personnel (performance bias)
All outcomes

High risk

Women and physicians knew which group was randomised to 'TVU CL performed' or 'not performed'

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported

Incomplete outcome data
(attrition bias)
All outcomes

High risk

Lost to follow-up removed from the analysis

Selective reporting (reporting bias)

Unclear risk

Unclear

Other bias

Low risk

Baseline characteristics similar

Ness 2007
Methods

RCT

Participants

Singleton (and 3 twin) pregnancies; uterine contractions or symptoms suggestive of PTL at 24 to 33 6/7
weeks. N = 100

Interventions

TVU CL knowledge or not (the control group did receive TVU CL, but results were blinded to managing
physicians)
Time TVU CL results available: not specified
Protocol for TVU knowledge group: yes

Outcomes

Primary: time from initial evaluation to discharge

Notes

Intention to treat; 97% singletons; protocol for management of TVU CL group, which included management based on FFN for women with CL 20 to 29 mm
Short TVU CL (< 20 mm): 11/51 (22%) in knowledge group; 7/49 (15%) in the control group
Funding: not reported
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Dates of trial: between November 2004 and April 2006
Setting: Thomas Jefferson University Hospital, Philadelphia
Conflicts of interest: not reported
Risk of bias
Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer-generated random numbers

Allocation concealment
(selection bias)

Low risk

Numbered, sealed, opaque envelopes

Blinding of participants
and personnel (performance bias)
All outcomes

High risk

Women and physicians knew which group was randomised to 'knowledge' or
'no knowledge'

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported

Incomplete outcome data
(attrition bias)
All outcomes

Low risk

Intention-to-treat analyses

Selective reporting (reporting bias)

Low risk

Primary outcome time from evaluation to discharge. All other outcomes reported

Other bias

Low risk

Baseline characteristics similar

Palacio 2018
Methods

RCT

Participants

Singleton pregnancies; PTL at 24 to 35 6/7 weeks. N = 149

Interventions

TVU CL knowledge or not (the control group did receive TVU CL, but results were blinded to managing
physicians)
Time TVU CL results available: not specified
Protocol for TVU knowledge group: yes

Outcomes

Primary: hospital length of stay

Notes

7 women lost to follow-up; only singletons; protocol for management of TVU CL group
Short TVU CL (< 25 mm): 22/75 (29%) in knowledge group; 20/74 (27%) in the control group
Funding: not reported
Dates of trial: from January 2002 to April 2005
Setting: Hospital Clinic of Barcelona, Spain
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Conflicts of interest: not reported
Risk of bias
Bias

Authors' judgement

Support for judgement
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5% of data removed from final analysis

Selective reporting (reporting bias)

Unclear risk

Length of hospital stay primary outcome

Other bias

Low risk

Baseline characteristics similar

Vafaei 2017
Methods

RCT

Participants

Singleton pregnancies; PTL before 34 weeks. N = 120

Interventions

TVU CL performed or not
Protocol for TVU group: yes

Outcomes

Primary: Delivery within 7 days

Notes

No outcome of interest
Funding: Supported by Vice-Chancellor of Research, Shiraz University of Medical Sciences, Shiraz, Iran
Dates of trial: not reported
Setting: Hafez Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Conflicts of interest: authors declare no conflict of interest
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Random sequence generation (selection bias)

Unclear risk

Randomisation not described

Allocation concealment
(selection bias)

Unclear risk

Not described

Blinding of participants
and personnel (performance bias)
All outcomes

High risk

Women and physicians knew which group was randomised to 'TVU CL performed' or 'not performed'

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not reported

Incomplete outcome data
(attrition bias)
All outcomes

Low risk

None lost to follow-up

Selective reporting (reporting bias)

Unclear risk

Unclear

Other bias

Low risk

Baseline characteristics similar

CL: cervical length
FFN: fetal fibronectin
PPROM: preterm premature rupture of membranes
PTL: preterm labour
RCT: randomised controlled trial
TVU: transvaginal ultrasound
US: ultrasound

Characteristics of excluded studies [ordered by study ID]
Study

Reason for exclusion

Beigi 2005

Compared history – indicated to ultrasound-indicated cerclage

Burwick 2011

Used Cervilenz, which is a plastic instrument to measure the vaginal part of the cervix. This is outside the scope of our review, which focuses on CL measured exclusively by TVU.

Gauthier 2014

Compared TVU CL screening to transperineal ultrasound CL screening, with no control group with
'no knowledge' of CL.

Hosseini 2012

Unclear if randomised to knowledge versus no knowledge of CL. No outcome of interest was reported in cases versus controls. Only published as an abstract, with no other information available.

Kassanos 2001

Compared history-indicated to ultrasound-indicated cerclage.

Lorenz 1990

Control group was not 'no ultrasound' or 'no knowledge', but was manual digital cervical exam. Interestingly, the study group utilized transabdominal ultrasound.

Matijevic 2006

The TVU CL information was blinded and not used for management.

Owen 1999

TVU information was not used for clinical care and no data on outcomes were provided.
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Study

Reason for exclusion

Romero 2014

No data on any outcomes of interest for this Cochrane Review were available, even upon direct request, as this was a trial assessing only visit length and patient attitudes.

Schnettler 2013

Compared TVU CL immediately after urination to TVU CL at least 15 minutes after urination, with
no control group with 'no knowledge' of CL.

Simcox 2009

Compared history – indicated to ultrasound-indicated cerclage.

Van Dijken 1991

Control group was not 'no ultrasound' or 'no knowledge', but was manual digital cervical exam. Interestingly, the study group utilized transabdominal, not TVU.

CL: cervical length
TVU: transvaginal ultrasound

Characteristics of ongoing studies [ordered by study ID]
NCT01431885
Trial name or title

Two methods of diagnosing preterm labor

Methods

Parallel open label randomised controlled trial

Participants

Symptomatic complaints suggestive of preterm labour, greater than 6 contractions per hour

Interventions

Symptomatic preterm labor patients will be randomised to diagnosis of preterm labor by serial digital examination versus an algorithm incorporating transvaginal ultrasound measurement of cervical length and vaginal fetal fibronectin.

Outcomes

Preterm birth < 37 weeks

Starting date

August 2011

Contact information

Conrad R Chao, University of California, San Francisco. e-mail: cchao@fresno.ucsf.edu

Notes

Estimated primary completion date: August 2015
Estimated study completion date: August 2015

NCT02923973
Trial name or title

Transvaginal ultrasound cervical length screening in singleton pregnancy with prior spontaneous
preterm birth

Methods

Parallel open label randomised trial

Participants

Women 18 to 50 years of age, with prior spontaneous preterm delivery 16 0/7 to 36 6/7 weeks and
singleton pregnancies

Interventions

Transvaginal ultrasound cervical length screening versus no screening

Outcomes

Primary:
Preterm birth (less than 37 weeks)
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Secondary:
Gestational age at delivery
Preterm birth (less than 24, 28, 32, 30, and 34 weeks' gestation)
Birthweight
Low birth weight (< 2500g)
Neonatal death
Composite of adverse perinatal outcomes (necrotizing enterocolitis, intraventricular haemorrhage
(grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy,
blood-culture proven sepsis and neonatal death)
Admission to neonatal intensive care unit
Starting date

June 1, 2018

Contact information

Gabriele Saccone, Federico II University, Naples, Italy, e-mail: gabriele.saccone.1990@gmail.com

Notes

Estimated primary completion date: December 1, 2020
Estimated study completion date: March 1, 2021

NCT02928302
Trial name or title

Transvaginal ultrasound cervical length screening in singleton pregnancy without prior spontaneous preterm birth

Methods

Non-blinded randomised screening trial

Participants

Asymptomatic singleton pregnancies without prior spontaneous preterm birth

Interventions

Transvaginal ultrasound cervical length screening versus no screening

Outcomes

Primary:
Preterm birth (less than 37 weeks)
Secondary:
Preterm birth (less than 24, 28, 32, 30, and 34 weeks' gestation)
Admission to neonatal intensive care unit
Neonatal death
Birthweight
Composite of adverse perinatal outcomes (necrotizing enterocolitis, intraventricular haemorrhage
(grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy,
blood-culture proven sepsis and neonatal death)
Perinatal death

Starting date

July 15, 2018

Contact information

Gabriele Saccone, Federico II University, Naples, Italy, e-mail: gabriele.saccone.1990@gmail.com
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Notes

Estimated primary completion date: September 2019
Estimated study completion date: January 2020

DATA AND ANALYSES
Comparison 1. Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) asymptomatic women with twins
Outcome or subgroup title

No. of
studies

No. of
participants

Statistical method

Effect size

1 Preterm birth < 36 weeks

1

125

Risk Ratio (M-H, Fixed, 95% CI)

1.27 [0.85, 1.90]

2 Preterm birth < 34 weeks

1

125

Risk Ratio (M-H, Fixed, 95% CI)

0.62 [0.30, 1.25]

3 Preterm birth < 32 weeks

1

125

Risk Ratio (M-H, Fixed, 95% CI)

0.56 [0.17, 1.83]

4 Preterm birth < 30 weeks

1

125

Risk Ratio (M-H, Fixed, 95% CI)

0.20 [0.02, 1.64]

5 Gestational age at delivery

1

125

Mean Difference (IV, Fixed, 95%
CI)

0.20 [-0.74, 1.14]

6 Maternal hospitalisation for PTL

1

125

Risk Ratio (M-H, Fixed, 95% CI)

1.29 [0.75, 2.23]

7 Tocolysis

1

125

Risk Ratio (M-H, Fixed, 95% CI)

1.34 [0.74, 2.42]

8 Steroids for fetal lung maturity

1

125

Risk Ratio (M-H, Fixed, 95% CI)

0.79 [0.49, 1.26]

9 Cervical cerclage

1

125

Risk Ratio (M-H, Fixed, 95% CI)

4.92 [0.24, 100.49]

10 Birthweight (g)

1

250

Mean Difference (IV, Fixed, 95%
CI)

142.0 [-9.95, 293.95]

11 NICU admission

1

250

Risk Ratio (M-H, Fixed, 95% CI)

1.14 [0.83, 1.55]

Analysis 1.1. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic women with twins, Outcome 1 Preterm birth < 36 weeks.
Study or subgroup

Gordon 2016

Total (95% CI)

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Weight

Risk Ratio
M-H, Fixed, 95% CI

31/63

24/62

100%

1.27[0.85,1.9]

63

62

100%

1.27[0.85,1.9]

Total events: 31 (Knowledge of CL), 24 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=1.17(P=0.24)
Favours knowledge of CL

0.1 0.2

0.5
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Analysis 1.2. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic women with twins, Outcome 2 Preterm birth < 34 weeks.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Gordon 2016

Weight

Risk Ratio
M-H, Fixed, 95% CI

10/63

16/62

100%

0.62[0.3,1.25]

63

62

100%

0.62[0.3,1.25]

Total (95% CI)

Total events: 10 (Knowledge of CL), 16 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=1.35(P=0.18)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 1.3. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic women with twins, Outcome 3 Preterm birth < 32 weeks.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Gordon 2016

Weight

Risk Ratio
M-H, Fixed, 95% CI

4/63

7/62

100%

0.56[0.17,1.83]

63

62

100%

0.56[0.17,1.83]

Total (95% CI)

Total events: 4 (Knowledge of CL), 7 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.96(P=0.34)
Favours knowledge of CL

0.02

0.1

1

10

50

Favours no knowledge of CL

Analysis 1.4. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic women with twins, Outcome 4 Preterm birth < 30 weeks.
Study or subgroup

Gordon 2016

Total (95% CI)

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Weight

Risk Ratio
M-H, Fixed, 95% CI

1/63

5/62

100%

0.2[0.02,1.64]

63

62

100%

0.2[0.02,1.64]

Total events: 1 (Knowledge of CL), 5 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=1.5(P=0.13)
Favours knowledge of CL

0.01

0.1

Cervical assessment by ultrasound for preventing preterm delivery (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

1

10

100

Favours no knowledge of CL

31

Cochrane

Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.5. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic women with twins, Outcome 5 Gestational age at delivery.
Study or subgroup

Knowledge of CL
N

Gordon 2016

63

Total ***

63

No knowledge of CL

Mean(SD)

N

35.7 (2.2)

Mean Difference

Mean(SD)

62

Weight

Fixed, 95% CI

Mean Difference
Fixed, 95% CI

35.5 (3.1)

62

100%

0.2[-0.74,1.14]

100%

0.2[-0.74,1.14]

Heterogeneity: Not applicable
Test for overall effect: Z=0.42(P=0.68)
Favours knowledge of CL

-4

-2

0

2

4

Favours no knowledge of CL

Analysis 1.6. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 6 Maternal hospitalisation for PTL.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Gordon 2016

Weight

Risk Ratio
M-H, Fixed, 95% CI

21/63

16/62

100%

1.29[0.75,2.23]

63

62

100%

1.29[0.75,2.23]

Total (95% CI)

Total events: 21 (Knowledge of CL), 16 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.92(P=0.36)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 1.7. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (CL) - asymptomatic women with twins, Outcome 7 Tocolysis.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Gordon 2016

Weight

Risk Ratio
M-H, Fixed, 95% CI

19/63

14/62

100%

1.34[0.74,2.42]

63

62

100%

1.34[0.74,2.42]

Total (95% CI)

Total events: 19 (Knowledge of CL), 14 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.95(P=0.34)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 1.8. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 8 Steroids for fetal lung maturity.
Study or subgroup

Gordon 2016

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

20/63

Weight

M-H, Fixed, 95% CI

25/62

Favours knowledge of CL

Risk Ratio

100%
0.01

0.1
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Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Total (95% CI)

63

Weight

Risk Ratio
M-H, Fixed, 95% CI

62

100%

0.79[0.49,1.26]

Total events: 20 (Knowledge of CL), 25 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.99(P=0.32)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 1.9. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic women with twins, Outcome 9 Cervical cerclage.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Gordon 2016

Weight

Risk Ratio
M-H, Fixed, 95% CI

2/63

0/62

100%

4.92[0.24,100.49]

63

62

100%

4.92[0.24,100.49]

Total (95% CI)

Total events: 2 (Knowledge of CL), 0 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=1.04(P=0.3)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 1.10. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic women with twins, Outcome 10 Birthweight (g).
Study or subgroup

Knowledge of CL

No knowledge of CL

N

Mean(SD)

N

Mean(SD)

Gordon 2016

126

2457 (540)

124

2315 (677)

Total ***

126

Mean Difference

Weight

Fixed, 95% CI

Mean Difference
Fixed, 95% CI

124

100%

142[-9.95,293.95]

100%

142[-9.95,293.95]

Heterogeneity: Not applicable
Test for overall effect: Z=1.83(P=0.07)
-200 -100

Favours knowledge of CL

0

100 200

Favours no knowledge of CL

Analysis 1.11. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic women with twins, Outcome 11 NICU admission.
Study or subgroup

Gordon 2016

Total (95% CI)

Knowledge of CL

No knowledge of CL

Risk Ratio

Weight

n/N

n/N

M-H, Fixed, 95% CI

Risk Ratio
M-H, Fixed, 95% CI

52/126

45/124

100%

1.14[0.83,1.55]

126

124

100%

1.14[0.83,1.55]

Total events: 52 (Knowledge of CL), 45 (No knowledge of CL)
Heterogeneity: Not applicable
Favours knowledge of CL

0.1

0.2

0.5
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Knowledge of CL

No knowledge of CL

Risk Ratio

Weight

n/N

n/N

M-H, Fixed, 95% CI

Risk Ratio
M-H, Fixed, 95% CI

Test for overall effect: Z=0.81(P=0.42)
0.1

Favours knowledge of CL

0.2

0.5

1

2

5

10

Favours no knowledge of CL

Comparison 2. Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) singletons with symptoms of PTL
Outcome or subgroup title

No. of
studies

No. of
participants

Statistical method

Effect size

1 Preterm birth < 37 weeks

2

242

Risk Ratio (M-H, Random, 95% CI)

0.59 [0.26, 1.32]

2 Preterm birth < 34 weeks

3

256

Risk Ratio (M-H, Fixed, 95% CI)

0.55 [0.25, 1.20]

3 Preterm birth < 28 weeks

2

137

Risk Ratio (M-H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4 Gestational age at delivery (weeks)

3

290

Mean Difference (IV, Fixed, 95%
CI)

0.64 [0.03, 1.25]

5 Birthweight < 2500 g

1

70

Risk Ratio (M-H, Fixed, 95% CI)

0.71 [0.21, 2.44]

6 Perinatal death

2

138

Risk Ratio (M-H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7 Maternal hospitalisation

1

93

Risk Ratio (M-H, Fixed, 95% CI)

2.94 [0.85, 10.16]

8 Tocolysis

2

102

Risk Ratio (M-H, Random, 95% CI)

0.85 [0.11, 6.58]

9 Steroids for fetal lung maturity

2

114

Risk Ratio (M-H, Random, 95% CI)

1.72 [0.15, 19.64]

Analysis 2.1. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - singletons with symptoms of PTL, Outcome 1 Preterm birth < 37 weeks.
Study or subgroup

Palacio 2018

Knowledge of CL

No knowledge of CL

Risk Ratio

Weight

n/N

n/N

M-H, Random, 95% CI

Risk Ratio
M-H, Random, 95% CI

21/75

25/74

58.63%

0.83[0.51,1.34]

Ness 2007

6/46

17/47

41.37%

0.36[0.16,0.83]

Total (95% CI)

121

121

100%

0.59[0.26,1.32]

Total events: 27 (Knowledge of CL), 42 (No knowledge of CL)
Heterogeneity: Tau2=0.23; Chi2=2.9, df=1(P=0.09); I2=65.5%
Test for overall effect: Z=1.29(P=0.2)
Favours knowledge of CL

0.01

0.1
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Analysis 2.2. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - singletons with symptoms of PTL, Outcome 2 Preterm birth < 34 weeks.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

Weight

n/N

n/N

M-H, Fixed, 95% CI

Risk Ratio
M-H, Fixed, 95% CI

Palacio 2018

4/59

7/59

43.38%

0.57[0.18,1.85]

Ness 2007

3/49

6/48

37.57%

0.49[0.13,1.85]

Alfirevic 2007

2/21

3/20

19.05%

0.63[0.12,3.41]

Total (95% CI)

129

127

100%

0.55[0.25,1.2]

Total events: 9 (Knowledge of CL), 16 (No knowledge of CL)
Heterogeneity: Tau2=0; Chi2=0.06, df=2(P=0.97); I2=0%
Test for overall effect: Z=1.49(P=0.14)
0.1 0.2

Favours knowledge of CL

0.5

1

2

5

10

Favours no knowledge of CL

Analysis 2.3. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - singletons with symptoms of PTL, Outcome 3 Preterm birth < 28 weeks.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

Weight

n/N

n/N

M-H, Fixed, 95% CI

Risk Ratio
M-H, Fixed, 95% CI

Alfirevic 2007

0/21

0/20

Not estimable

Ness 2007

0/48

0/48

Not estimable

69

68

Not estimable

Total (95% CI)

Total events: 0 (Knowledge of CL), 0 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 2.4. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 4 Gestational age at delivery (weeks).
Study or subgroup

Knowledge of CL
N

Mean(SD)

No knowledge of CL
N

Mean Difference

Mean(SD)

Weight

Fixed, 95% CI

Mean Difference
Fixed, 95% CI

Palacio 2018

75

37.6 (2.6)

74

37.3 (2.7)

51.2%

0.3[-0.55,1.15]

Alfirevic 2007

21

37.9 (3)

20

37.6 (2.9)

11.38%

0.3[-1.51,2.11]

Ness 2007

51

38.3 (2.1)

49

37.1 (2.9)

37.42%

1.2[0.2,2.2]

Total ***

147

100%

0.64[0.03,1.25]

143

Heterogeneity: Tau2=0; Chi2=1.96, df=2(P=0.37); I2=0%
Test for overall effect: Z=2.05(P=0.04)
Favours no knowledge of CL
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Analysis 2.5. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - singletons with symptoms of PTL, Outcome 5 Birthweight < 2500 g.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Ness 2007

Weight

Risk Ratio
M-H, Fixed, 95% CI

4/37

5/33

100%

0.71[0.21,2.44]

37

33

100%

0.71[0.21,2.44]

Total (95% CI)

Total events: 4 (Knowledge of CL), 5 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.54(P=0.59)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 2.6. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - singletons with symptoms of PTL, Outcome 6 Perinatal death.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Weight

Risk Ratio
M-H, Fixed, 95% CI

Ness 2007

0/49

0/48

Not estimable

Alfirevic 2007

0/21

0/20

Not estimable

70

68

Not estimable

Total (95% CI)

Total events: 0 (Knowledge of CL), 0 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 2.7. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - singletons with symptoms of PTL, Outcome 7 Maternal hospitalisation.
Study or subgroup

Ness 2007

Total (95% CI)

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Weight

Risk Ratio
M-H, Fixed, 95% CI

9/47

3/46

100%

2.94[0.85,10.16]

47

46

100%

2.94[0.85,10.16]

Total events: 9 (Knowledge of CL), 3 (No knowledge of CL)
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%
Test for overall effect: Z=1.7(P=0.09)
Favours knowledge of CL

0.01

0.1
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Analysis 2.8. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (CL) - singletons with symptoms of PTL, Outcome 8 Tocolysis.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

Weight

n/N

n/N

M-H, Random, 95% CI

Risk Ratio
M-H, Random, 95% CI

Ness 2007

9/39

2/22

44.88%

2.54[0.6,10.72]

Alfirevic 2007

7/21

20/20

55.12%

0.35[0.19,0.63]

60

42

100%

0.85[0.11,6.58]

Total (95% CI)

Total events: 16 (Knowledge of CL), 22 (No knowledge of CL)
Heterogeneity: Tau2=1.89; Chi2=7, df=1(P=0.01); I2=85.72%
Test for overall effect: Z=0.16(P=0.88)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 2.9. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 9 Steroids for fetal lung maturity.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Random, 95% CI

Alfirevic 2007
Ness 2007
Total (95% CI)

Weight

Risk Ratio
M-H, Random, 95% CI

18/21

20/20

54.39%

0.86[0.71,1.05]

9/39

2/34

45.61%

3.92[0.91,16.92]

60

54

100%

1.72[0.15,19.64]

Total events: 27 (Knowledge of CL), 22 (No knowledge of CL)
Heterogeneity: Tau2=2.83; Chi2=11, df=1(P=0); I2=90.91%
Test for overall effect: Z=0.44(P=0.66)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Comparison 3. Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) singletons with PPROM
Outcome or subgroup title

No. of
studies

No. of
participants

Statistical method

Effect size

1 Birthweight (g)

1

92

Mean Difference (IV, Fixed, 95% CI)

31.0 [-162.16, 224.16]

2 Chorioamnionitis

1

92

Risk Ratio (M-H, Fixed, 95% CI)

0.72 [0.34, 1.52]

3 Endometritis

1

92

Risk Ratio (M-H, Fixed, 95% CI)

1.39 [0.33, 5.88]

4 Neonatal infection

1

92

Risk Ratio (M-H, Fixed, 95% CI)

1.18 [0.50, 2.78]
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Analysis 3.1. Comparison 3 Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (CL) - singletons with PPROM, Outcome 1 Birthweight (g).
Study or subgroup

Knowledge of CL
N

Carlan 1997

45

Total ***

45

Mean(SD)
1617 (500)

No knowledge of CL
N

Mean Difference

Mean(SD)

47

Weight

Fixed, 95% CI

Mean Difference
Fixed, 95% CI

1586 (442)

47

100%

31[-162.16,224.16]

100%

31[-162.16,224.16]

Heterogeneity: Not applicable
Test for overall effect: Z=0.31(P=0.75)
-200

Favours knowledge of CL

-100

0

100

200

Favours no knowledge of CL

Analysis 3.2. Comparison 3 Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (CL) - singletons with PPROM, Outcome 2 Chorioamnionitis.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Carlan 1997

Weight

Risk Ratio
M-H, Fixed, 95% CI

9/45

13/47

100%

0.72[0.34,1.52]

45

47

100%

0.72[0.34,1.52]

Total (95% CI)

Total events: 9 (Knowledge of CL), 13 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.85(P=0.39)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 3.3. Comparison 3 Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (CL) - singletons with PPROM, Outcome 3 Endometritis.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Carlan 1997

Weight

Risk Ratio
M-H, Fixed, 95% CI

4/45

3/47

100%

1.39[0.33,5.88]

45

47

100%

1.39[0.33,5.88]

Total (95% CI)

Total events: 4 (Knowledge of CL), 3 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.45(P=0.65)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 3.4. Comparison 3 Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (CL) - singletons with PPROM, Outcome 4 Neonatal infection.
Study or subgroup

Carlan 1997

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

9/45

Weight

M-H, Fixed, 95% CI

8/47

Favours knowledge of CL

Risk Ratio

100%
0.01

0.1
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1.18[0.5,2.78]
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Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Total (95% CI)

45

Weight

Risk Ratio
M-H, Fixed, 95% CI

47

100%

1.18[0.5,2.78]

Total events: 9 (Knowledge of CL), 8 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.37(P=0.71)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Comparison 4. Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) asymptomatic singletons
Outcome or subgroup title

No. of
studies

No. of
participants

Statistical method

Effect size

1 Preterm birth < 37 weeks

1

296

Risk Ratio (M-H, Fixed, 95% CI)

1.27 [0.61, 2.61]

2 Birthweight (g)

1

296

Mean Difference (IV, Fixed, 95%
CI)

-10.0 [-135.17, 115.17]

3 Respiratory distress syndrome (RDS)

1

296

Risk Ratio (M-H, Fixed, 95% CI)

2.03 [0.38, 10.90]

4 NICU admission

1

296

Risk Ratio (M-H, Fixed, 95% CI)

2.03 [0.19, 22.12]

5 Intraventricular haemorrhage (IVH)

1

296

Risk Ratio (M-H, Fixed, 95% CI)

0.51 [0.05, 5.53]

6 Neonatal death

1

296

Risk Ratio (M-H, Fixed, 95% CI)

0.20 [0.01, 4.19]

Analysis 4.1. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic singletons, Outcome 1 Preterm birth < 37 weeks.
Study or subgroup

Mishra 2018

Total (95% CI)

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Weight

Risk Ratio
M-H, Fixed, 95% CI

15/147

12/149

100%

1.27[0.61,2.61]

147

149

100%

1.27[0.61,2.61]

Total events: 15 (Knowledge of CL), 12 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.64(P=0.52)
Favours knowledge of CL

0.01

0.1
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Analysis 4.2. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (CL) - asymptomatic singletons, Outcome 2 Birthweight (g).
Study or subgroup

Knowledge of CL

No knowledge of CL

N

Mean(SD)

N

Mean(SD)

Mishra 2018

147

2900 (603)

149

2910 (489)

Total ***

147

Mean Difference

Weight

Fixed, 95% CI

Mean Difference
Fixed, 95% CI

149

100%

-10[-135.17,115.17]

100%

-10[-135.17,115.17]

Heterogeneity: Not applicable
Test for overall effect: Z=0.16(P=0.88)
Favours knowledge of CL

-100

-50

0

50

100

Favours no knowledge of CL

Analysis 4.3. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic singletons, Outcome 3 Respiratory distress syndrome (RDS).
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Mishra 2018

Total (95% CI)

Weight

Risk Ratio
M-H, Fixed, 95% CI

4/147

2/149

100%

2.03[0.38,10.9]

147

149

100%

2.03[0.38,10.9]

Total events: 4 (Knowledge of CL), 2 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.82(P=0.41)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 4.4. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (CL) - asymptomatic singletons, Outcome 4 NICU admission.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Mishra 2018

Total (95% CI)

Weight

Risk Ratio
M-H, Fixed, 95% CI

2/147

1/149

100%

2.03[0.19,22.12]

147

149

100%

2.03[0.19,22.12]

Total events: 2 (Knowledge of CL), 1 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.58(P=0.56)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 4.5. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)measured cervical length (CL) - asymptomatic singletons, Outcome 5 Intraventricular haemorrhage (IVH).
Study or subgroup

Mishra 2018

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

1/147

Weight

M-H, Fixed, 95% CI

2/149

Favours knowledge of CL

Risk Ratio

100%
0.01

0.1
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Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Total (95% CI)

147

Weight

Risk Ratio
M-H, Fixed, 95% CI

149

100%

0.51[0.05,5.53]

Total events: 1 (Knowledge of CL), 2 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=0.56(P=0.58)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

Analysis 4.6. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (CL) - asymptomatic singletons, Outcome 6 Neonatal death.
Study or subgroup

Knowledge of CL

No knowledge of CL

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

Mishra 2018

Total (95% CI)

Weight

Risk Ratio
M-H, Fixed, 95% CI

0/147

2/149

100%

0.2[0.01,4.19]

147

149

100%

0.2[0.01,4.19]

Total events: 0 (Knowledge of CL), 2 (No knowledge of CL)
Heterogeneity: Not applicable
Test for overall effect: Z=1.03(P=0.3)
Favours knowledge of CL

0.01

0.1

1

10

100

Favours no knowledge of CL

APPENDICES
Appendix 1. ICTRP and ClinicalTrials.gov - search methods
ICTRP
Each line was run separately
ultrasound AND preterm
sonography AND preterm
cervical AND length AND pregnancy
cervical AND length AND preterm
ClinicalTrials.gov
Advanced search
Interventional studies | Preterm Labor | ultrasound
Cervical length | Interventional studies | preterm
pregnancy | Interventional studies | cervical length
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Date

Event

Description

30 August 2018

New citation required but conclusions
have not changed

Conclusions remain unchanged.

30 August 2018

New search has been performed

Search updated and two new studies included (Mishra 2018;
Vafaei 2017). A 'Summary of findings' table has been incorporated.

HISTORY
Protocol first published: Issue 3, 2008
Review first published: Issue 3, 2009

Date

Event

Description

28 January 2013

Amended

Information added on attrition bias for one study (Ness 2007).

26 September 2012

New search has been performed

Two studies identified from an updated search have been assessed for eligibility and both have been excluded. Methods have
been updated.

26 September 2012

New citation required but conclusions
have not changed

Review updated.

27 January 2012

Amended

Search updated. Two trial reports added to Studies awaiting
classification (Burwick 2011; Simcox 2009).
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NIHR Programme of centrally-managed pregnancy and childbirth systematic reviews of priority to the NHS and users of the NHS:
10/4001/02

DIFFERENCES BETWEEN PROTOCOL AND REVIEW
A number of outcomes not prespecified in the original protocol were included in the first review, as listed below. We used the same outcomes in this revision.
1.
2.
3.
4.
5.
6.

Preterm birth (less than 36 weeks)
Preterm birth (less than 30 weeks)
Birthweight
Neonatal infection
Chorioamnionitis
Endometritis

We added a search of ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP).
We clarified the inclusion criteria, as follows:
Trials that did not measure the outcome of interest, as well as trials using manual digital cervical exam as control group were excluded.
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Medical Subject Headings (MeSH)
Cervical Length Measurement [*methods]; Cervix Uteri [*diagnostic imaging]; Pregnancy, Multiple; Pregnancy, Twin; Premature Birth
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MeSH check words
Female; Humans; Pregnancy
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